Connection

Donald Castell to Omeprazole

Back to Details
This is a "connection" page, showing publications Donald Castell has written about Omeprazole.
Donald Castell
Connection Strength
5.826
Omeprazole
  1. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression. Pharmacotherapy. 2015 Dec; 35(12):1124-9.
    View in: PubMed
    Score: 0.508
  2. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin Pharmacother. 2005 Nov; 6(14):2501-10.
    View in: PubMed
    Score: 0.252
  3. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005 Jun 15; 21(12):1467-74.
    View in: PubMed
    Score: 0.246
  4. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors. Aliment Pharmacol Ther. 2002 Mar; 16(3):473-7.
    View in: PubMed
    Score: 0.196
  5. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001 Jun; 120(7):1599-606.
    View in: PubMed
    Score: 0.186
  6. Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg. Aliment Pharmacol Ther. 2001 May; 15(5):647-52.
    View in: PubMed
    Score: 0.185
  7. Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Aliment Pharmacol Ther. 2001 Apr; 15(4):519-24.
    View in: PubMed
    Score: 0.184
  8. Aggressive acid control: minimizing progression of Barrett's esophagus. Am J Manag Care. 2001 Feb; 7(1 Suppl):S15-8.
    View in: PubMed
    Score: 0.182
  9. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther. 2000 Jun; 14(6):709-14.
    View in: PubMed
    Score: 0.173
  10. Importance of adequate acid suppression in the management of Barrett's esophagus. Gastroenterology. 1999 Dec; 117(6):1509-10.
    View in: PubMed
    Score: 0.167
  11. A practical approach to heartburn. Hosp Pract (1995). 1999 Nov 15; 34(12):89-94, 97-8.
    View in: PubMed
    Score: 0.167
  12. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. N Engl J Med. 2019 10 17; 381(16):1513-1523.
    View in: PubMed
    Score: 0.166
  13. Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers. Aliment Pharmacol Ther. 1999 Sep; 13(9):1211-4.
    View in: PubMed
    Score: 0.165
  14. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH. Aliment Pharmacol Ther. 1999 May; 13(5):675-8.
    View in: PubMed
    Score: 0.161
  15. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology. 1998 Dec; 115(6):1335-9.
    View in: PubMed
    Score: 0.156
  16. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther. 1998 Dec; 12(12):1231-4.
    View in: PubMed
    Score: 0.156
  17. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther. 1998 Dec; 12(12):1235-40.
    View in: PubMed
    Score: 0.156
  18. The acid suppression test for unexplained chest pain. Gastroenterology. 1998 Jul; 115(1):222-4.
    View in: PubMed
    Score: 0.152
  19. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol. 1998 May; 93(5):763-7.
    View in: PubMed
    Score: 0.150
  20. Acid control and regression of Barrett's esophagus: is the glass half full or half empty? Am J Gastroenterol. 1997 Dec; 92(12):2329-30.
    View in: PubMed
    Score: 0.146
  21. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci. 1997 Oct; 42(10):2138-45.
    View in: PubMed
    Score: 0.144
  22. Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules. Dig Dis Sci. 1997 Apr; 42(4):715-9.
    View in: PubMed
    Score: 0.139
  23. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Am J Gastroenterol. 1997 Mar; 92(3):429-37.
    View in: PubMed
    Score: 0.138
  24. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol. 1996 Oct; 91(10):2110-3.
    View in: PubMed
    Score: 0.134
  25. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Am J Gastroenterol. 1996 Sep; 91(9):1749-57.
    View in: PubMed
    Score: 0.134
  26. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol. 1996 Aug; 91(8):1527-31.
    View in: PubMed
    Score: 0.133
  27. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996 Aug; 91(8):1532-8.
    View in: PubMed
    Score: 0.133
  28. Omeprazole works best when used properly. Eur J Gastroenterol Hepatol. 1996 May; 8(5):413-4.
    View in: PubMed
    Score: 0.131
  29. Omeprazole for the treatment of posterior laryngitis. Am J Med. 1995 Dec; 99(6):694-5.
    View in: PubMed
    Score: 0.127
  30. Omeprazole, serum gastrin, and gastric acid suppression. Ann Intern Med. 1995 Feb 01; 122(3):237-8.
    View in: PubMed
    Score: 0.120
  31. Omeprazole failure in a patient with gastroesophageal reflux disease. Ann Intern Med. 1994 Dec 01; 121(11):899.
    View in: PubMed
    Score: 0.118
  32. The acidity index: a simple approach to the measurement of gastric acidity. Aliment Pharmacol Ther. 2004 Feb 15; 19(4):443-8.
    View in: PubMed
    Score: 0.056
  33. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Aliment Pharmacol Ther. 2002 Apr; 16(4):829-36.
    View in: PubMed
    Score: 0.049
  34. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal. Aliment Pharmacol Ther. 2000 Oct; 14(10):1267-72.
    View in: PubMed
    Score: 0.044
  35. Acid suppression therapy in Barrett's esophagus: the importance of pH monitoring. Curr Gastroenterol Rep. 2000 Jun; 2(3):173-4.
    View in: PubMed
    Score: 0.043
  36. Medical therapy. Management of the refractory patient. Gastroenterol Clin North Am. 1999 Dec; 28(4):847-60.
    View in: PubMed
    Score: 0.042
  37. Current medical treatment and indications for surgical referral for gastroesophageal reflux disease (GERD). Semin Thorac Cardiovasc Surg. 1997 Apr; 9(2):169-72.
    View in: PubMed
    Score: 0.035
  38. Health-related quality of life of patients with acute erosive reflux esophagitis. Dig Dis Sci. 1996 Nov; 41(11):2123-9.
    View in: PubMed
    Score: 0.034
  39. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol. 1996 Sep; 91(9):1715-8.
    View in: PubMed
    Score: 0.033
  40. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA. 2016 May 17; 315(19):2104-12.
    View in: PubMed
    Score: 0.033
  41. Excluding gastroesophageal reflux disease as the cause of chronic cough. J Clin Gastroenterol. 1996 Apr; 22(3):168-9.
    View in: PubMed
    Score: 0.032
  42. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases. Am J Gastroenterol. 1995 Oct; 90(10):1874-7.
    View in: PubMed
    Score: 0.031
  43. Gastroesophageal reflux laryngitis resistant to omeprazole therapy. J Voice. 1995 Jun; 9(2):205-11.
    View in: PubMed
    Score: 0.031
  44. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol. 1994 Jul; 89(7):989-91.
    View in: PubMed
    Score: 0.029
  45. Long-term management of GERD: the pill, the knife, or the endoscope? Gastrointest Endosc. 1994 Mar-Apr; 40(2 Pt 1):252-3.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.